Physician profile
Ryan P Tetting
NPI 1982850475
$1,353.11
in general payments reported to CMS, 2019-2025
16 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $96.52 · 2021: $205 · 2022: $175 · 2023: $157 · 2024: $163 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $219.84 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $213.33 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.99 | 2019-2021 | |
| Allergan, INC. | $124.27 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $113.50 | 2019-2025 | |
| Tarsus Pharmaceuticals, INC. | $85.34 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $84.93 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Coopervision INC. | $81.14 | 2019-2024 | Myday Contact Lens |
| Kala Pharmaceuticals, INC. | $75.18 | 2021-2022 | |
| Alcon Vision LLC | $68.97 | 2019-2025 | Eysuvis, Total30 |
| Abbvie INC. | $59.11 | 2023-2025 | Vuity, Lumigan, Alphagan P |
| Shire North American Group INC | $27.14 | 2019 | |
| Thea Pharma INC. | $26.49 | 2025 | Iyuzeh |
| Horizon Therapeutics Plc | $22.12 | 2023 | Tepezza |
| Dompe US, INC. | $15.04 | 2025 | Oxervate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $10.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Tetting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.